Displaying 10 out of 7 results

  1. FILE PHOTO: Logo of Swiss drugmaker Novartis is seen at its branch in Schweizerhalle near Basel

    Novartis halts distribution of its Zantac versions amid probe into impurities

    Novartis AG's Sandoz unit said on Wednesday it was halting distribution of its versions of the drug commonly known as Zantac in all its markets, ...
  2. FILE PHOTO: Novartis CEO Vas Narasimhan

    Novartis CEO pledges not to sell Sandoz generics unit

    Novartis Chief Executive Vas Narasimhan pledged in an interview published on Saturday not to sell the Swiss drugmaker's generics unit Sandoz amid ...
  3. FILE PHOTO: Switzerland's national flag flies in front of the logo of Swiss drugmaker Novartis

    Novartis raises 2019 guidance, helped by Sandoz generics unit

    Novartis lifted full-year sales and profit targets on Thursday, helped by innovative medicine sales and as the Swiss drugmaker's slimmed-down ...
  4. FILE PHOTO: Swiss drugmaker Novartis' logo is seen in Stein

    Novartis's Sandoz strikes deal for biosimilar of Herceptin

    Novartis's Sandoz division has struck a deal with Taiwan's EirGenix Inc to market a biosimilar version of Roche's Herceptin that is now in ...
  5. FILE PHOTO: Richard Francis talks during an interview with Reuters in Basel

    Novartis generics boss quits amid conjecture over business's future

    Novartis's generics chief is quitting after the Swiss drugmaker sold parts of the business and initiated an 18-month revamp, fueling speculation ...
  6. FILE PHOTO: Swiss drugmaker Novartis' logo is seen in Stein

    Novartis 'completely committed' to Sandoz, has no split-off plan

    Swiss drugmaker Novartis is "completely committed" to its US$10 billion-per-year Sandoz generics business, a spokesman said on Thursday, after a ...